MRNA

NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$51.34

+0.06 (+0.12%)

As of Mar 24, 9:41 PM ET ·

Day Range $50.34 — $52.68

52W Range $22.28 — $55.20

Performance

1D —

1W —

1M —

3M +64.55%

6M +109.64%

1Y +51.67%

YTD +66.36%

Open$50.44

Previous Close$51.28

Day High$52.68

Day Low$50.34

52W High$55.20

52W Low$22.28

Volume—

Avg Volume11.22M

Market Cap19.42B

P/E Ratio—

EPS$-7.26

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $37.98 Above

SMA 200 $29.64 Above

RSI (14) 57.2 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Hold

30 analysts

3 Buy 21 Hold 6 Sell

Price Target +191.1% upside

Current
$51.34

Target
$149.45

$89.97 $149.45 avg $212.09

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	2.37B	5.08B	2.23B
Net Income	-3,435,222,270	-6,640,249,233	-285,156,561
Profit Margin	-145.2%	-137.9%	-12.8%
EBITDA	-3,490,009,673	-7,120,938,980	-355,384,473
Free Cash Flow	—	—	-237,052,091
Rev Growth	-53.4%	-53.4%	+3.0%
Debt/Equity	0.07	0.07	0.52

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$205.20	+0.13%	166.6	397.77B
AMGN	Amgen Inc	$348.43	-0.38%	24.4	188.06B
GILD	Gilead Sciences Inc	$138.11	+0.56%	20.0	170.34B
VRTX	Vertex Pharmaceuticals Inc	$448.62	-0.58%	29.2	115.53B
REGN	Regeneron Pharmaceuticals	$741.69	+0.70%	17.9	80.50B
ALNY	Alnylam Pharmaceuticals Inc	$308.05	+0.45%	139.7	43.84B